Pages that link to "Q87267613"
Jump to navigation
Jump to search
The following pages link to PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients (Q87267613):
Displaying 50 items.
- The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis (Q26748691) (← links)
- A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers (Q26777111) (← links)
- Human Cancer Immunotherapy with PD-1/PD-L1 Blockade (Q26786108) (← links)
- Relevance of tumor-infiltrating lymphocytes in breast cancer (Q26795598) (← links)
- Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients (Q33579474) (← links)
- Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis (Q33644049) (← links)
- Precision medicine in breast cancer: reality or utopia? (Q33809114) (← links)
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. (Q34809019) (← links)
- PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer (Q35713307) (← links)
- The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis (Q35754821) (← links)
- Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis (Q35811294) (← links)
- Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis. (Q36114808) (← links)
- Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes (Q36344920) (← links)
- Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. (Q36577841) (← links)
- Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis. (Q36772903) (← links)
- Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. (Q37335249) (← links)
- Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells (Q37362929) (← links)
- Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer (Q37611683) (← links)
- Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes (Q37706368) (← links)
- Role of tumor microenvironment in tumorigenesis (Q37738074) (← links)
- Natural and therapy-induced immunosurveillance in breast cancer (Q38601420) (← links)
- A review of the importance of immune responses in luminal B breast cancer. (Q39239484) (← links)
- Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis (Q40694392) (← links)
- Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis (Q41445876) (← links)
- Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection (Q41547569) (← links)
- miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion (Q41992370) (← links)
- Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis. (Q42682646) (← links)
- Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis (Q47094412) (← links)
- Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model (Q47100953) (← links)
- High PD-L1 Expression Is Closely Associated With Tumor-Infiltrating Lymphocytes and Leads to Good Clinical Outcomes in Chinese Triple Negative Breast Cancer Patients (Q47125869) (← links)
- Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tu (Q48121626) (← links)
- Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma. (Q52721812) (← links)
- Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. (Q52755645) (← links)
- Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients. (Q55083652) (← links)
- Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. (Q55278851) (← links)
- Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. (Q55362114) (← links)
- A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease. (Q55456412) (← links)
- Distribution of CD4 and CD8 exhausted tumor-infiltrating lymphocytes in molecular subtypes of Chinese breast cancer patients (Q57071375) (← links)
- Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients (Q58698521) (← links)
- PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer (Q60917378) (← links)
- The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer (Q64256609) (← links)
- Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy. (Q64942268) (← links)
- Immunological microenvironment gene expression in patients with diffuse large B cell non Hodgkin lymphoma (Q89560770) (← links)
- Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors (Q90226731) (← links)
- Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases (Q90470271) (← links)
- PD-1-Associated Gene Expression Signature of Neoadjuvant Trastuzumab-Treated Tumors Correlates with Patient Survival in HER2-Positive Breast Cancer (Q90749764) (← links)
- Molecular stratification within triple-negative breast cancer subtypes (Q91973648) (← links)
- Comprehensive in vitro characterization of PD-L1 small molecule inhibitors (Q92913854) (← links)
- Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients (Q96815990) (← links)
- Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma (Q96954585) (← links)